CUCINOTTA, MARIAPAOLA
 Distribuzione geografica
Continente #
EU - Europa 6.438
NA - Nord America 1.690
AS - Asia 930
SA - Sud America 320
AF - Africa 38
OC - Oceania 4
Totale 9.420
Nazione #
IT - Italia 4.111
US - Stati Uniti d'America 1.656
RU - Federazione Russa 1.139
SG - Singapore 337
NL - Olanda 285
CN - Cina 281
BR - Brasile 266
IE - Irlanda 257
SE - Svezia 215
DE - Germania 117
HK - Hong Kong 86
FI - Finlandia 66
GB - Regno Unito 65
FR - Francia 61
VN - Vietnam 61
IN - India 55
PL - Polonia 39
CA - Canada 17
BD - Bangladesh 15
AR - Argentina 14
TR - Turchia 14
IQ - Iraq 13
UA - Ucraina 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
ES - Italia 12
CO - Colombia 11
IR - Iran 10
BE - Belgio 9
MX - Messico 9
ZA - Sudafrica 8
CI - Costa d'Avorio 7
CL - Cile 7
EC - Ecuador 7
JP - Giappone 7
PK - Pakistan 7
KE - Kenya 6
SA - Arabia Saudita 6
PY - Paraguay 5
TN - Tunisia 5
AL - Albania 4
AZ - Azerbaigian 4
EG - Egitto 4
ID - Indonesia 4
KZ - Kazakistan 4
LT - Lituania 4
MA - Marocco 4
PH - Filippine 4
UY - Uruguay 4
UZ - Uzbekistan 4
AU - Australia 3
JM - Giamaica 3
NP - Nepal 3
RO - Romania 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AT - Austria 2
BH - Bahrain 2
BY - Bielorussia 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
IL - Israele 2
LB - Libano 2
LY - Libia 2
MY - Malesia 2
PE - Perù 2
AM - Armenia 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
DZ - Algeria 1
GA - Gabon 1
GR - Grecia 1
HN - Honduras 1
KG - Kirghizistan 1
KI - Kiribati 1
LK - Sri Lanka 1
LU - Lussemburgo 1
NO - Norvegia 1
PT - Portogallo 1
QA - Qatar 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SM - San Marino 1
Totale 9.420
Città #
Milan 409
Rome 349
Moscow 318
Dublin 256
Ashburn 245
Dallas 241
Chandler 215
Singapore 204
Naples 172
Nyköping 136
Beijing 123
San Jose 92
Turin 86
Hong Kong 85
Bari 75
Bologna 70
Munich 70
Palermo 65
The Dalles 63
Florence 58
Jacksonville 51
Catania 48
Dearborn 48
Genoa 48
Los Angeles 42
New York 42
Cambridge 34
Princeton 34
Warsaw 33
Lauterbourg 32
Medford 32
Des Moines 30
Messina 27
Trieste 27
Modena 25
Cagliari 24
Hyderabad 24
Brescia 23
Pisa 22
Turku 22
Ann Arbor 21
Lancaster 21
São Paulo 21
Jinan 20
Verona 20
Buffalo 17
Padova 17
Parma 17
Bergamo 16
Hanoi 16
Ho Chi Minh City 15
Pune 15
Cascina 14
Nanjing 14
Cosenza 13
Houston 13
Monza 13
Novara 12
Orem 12
Pescara 12
Prato 12
Reggio Emilia 12
San Mateo 12
Boardman 11
Bremen 11
Padua 11
Modugno 10
Perugia 10
Udine 10
Venice 10
Brussels 9
Civitanova Marche 9
Denver 9
London 9
Lucca 9
Sassari 9
Shenyang 9
Taranto 9
Ancona 8
Atlanta 8
Helsinki 8
Montreal 8
Ningbo 8
Redondo Beach 8
Rio de Janeiro 8
Abidjan 7
Brasília 7
Eboli 7
Frankfurt am Main 7
Hebei 7
Johannesburg 7
Livorno 7
Oristano 7
Ravenna 7
Treviglio 7
Vicenza 7
Wilmington 7
Aversa 6
Brno 6
Brooklyn 6
Totale 4.658
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.565
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 204
A didactic experiment showing the Compton scattering by means of a clinical gamma camera 201
2 years-survival analysis of patients with non-small cell lung cancer by means of 2deoxy-2-[18F]fluoro-D-glucose positron emission tomography: implications of maximum standardized uptake value (SUVmax) 197
THIONAMIDES-RELATED VASCULITIS IN AUTOIMMUNE THYROID DISORDERS: REVIEW OF CURRENT LITERATURE AND CASE REPORTS 196
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 187
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 181
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 180
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 177
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 170
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 169
A potentially misleading finding at somatostatin receptor scintigraphy: focal pulmonary areas of intense accumulation without computed tomography-detectable lung lesions 164
Oxidative Stress: Harms and Benefits for Human Health 162
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 158
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 157
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 155
Hyperthyroidism treatment with calculated activity of 131–radioiodine 154
Is %ΔSUVmax a Useful Indicator of Survival in Patients with Advanced Nonsmall-Cell Lung Cancer? 146
Is Detection of Additional Lesions in Post-Peptide ReceptorRadionuclide Therapy Scans With Respect to DiagnosticImaging Only Due to Different Affinity of Ligands?A Report of Discordance Between Diagnostic and Posttherapy Imaging Using the Same Ligand 145
High grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 140
High-grade gliomas associated with abscess: description of two rare cases and role of 99mTc-Leukoscan 140
Middle-Term Outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 131
IMPIEGO DEL 99mTC-MIBI PER VALUTARE IL RISCHIO DI MALIGNITA’ DEL NODULO TIROIDEO 130
Lack of association between autonomously functioning thyroid nodules and germline polymorphisms of the thyrotropin receptor and Gαs genes in a mild to moderate iodine-deficient Caucasian population 130
Our experience with peptide receptor radionuclide therapy in patients affected by pulmonary neuroendocrine tumors 128
Middle-term outcome and safety of hyperthyroid patients treated with calculated activity of radioiodine 118
Peptide receptor imaging in neuroendocrine tumors: comparison between diagnostic scintigraphy and post-therapy whole-body scan 116
Is pre-treatment SUVmax an useful indicator of survival in patients with advanced non-small-cell lung cancer? 115
Renal function evaluation in patients undergoing repeated peptide receptor radionuclide therapy 107
Gliomas with intratumoral abscess formation: Description of new cases, review of the literature, and the role of (99m)TC-Leukoscan 106
VANTAGGI DELLA DOSIMETRIA PERSONALIZZATA VS ATTIVITA’ STANDARD DI RADIOIODIO NELLA TERAPIA DELL’IPERTIROIDISMO: LA NOSTRA ESPERIENZA 97
Two-year survival prediction in patients with stage I and II non-small cell lung cancer utilizing 18F-FDG PET/CT SUV quantification 97
Stage III-IV non small cell lung cancer: the impact of SUVmax and %SUVmax in predicting survival after chemotherapy 89
RADIOIODINE UPTAKE IN ABDOMINAL DERMOID CYST IN A PATIENT WITH DIFFERENTIATED THYROID CANCER (DTC) 79
null 42
null 27
Totale 9.460
Categoria #
all - tutte 20.007
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.007


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202140 0 0 0 0 0 0 0 0 0 12 22 6
2021/2022249 1 30 1 8 15 1 29 8 1 49 30 76
2022/2023787 62 107 36 63 47 59 21 40 307 15 22 8
2023/20241.374 22 50 72 73 70 134 103 123 96 202 178 251
2024/20253.215 216 141 234 328 268 198 229 459 390 244 234 274
2025/20263.249 240 252 303 259 276 592 365 382 412 168 0 0
Totale 9.460